Rathinam Sridhar, Nanjaiah Prakash, Sivalingam Sivakumar, Rajesh Pala B
Regional Department of Thoracic Surgery, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, UK.
J Cardiothorac Surg. 2008 Aug 13;3:50. doi: 10.1186/1749-8090-3-50.
Video-Assisted Thoracoscopic Sympathectomy (VATS) is an established minimally invasive procedure for thoracic sympathetic blockade in patients with hyperhidrosis, facial flushing and intractable angina. Various techniques using clips, diathermy and excision are used to perform sympathectomy. We present our technique of excision of the sympathetic chain with histological proof and the analysis of the early and late outcomes.
We evaluated 200 procedures in 100 consecutive patients, who underwent Video Assisted Thoracoscopic Sympathectomy by a single surgeon in our centre between September 1996 to March 2007. All patients had maximum medical therapy prior to surgery and were divided into 3 groups based on indications, Group 1(hyperhidrosis: 48 patients), Group 2 (facial flushing: 26 patients) and Group 3(intractable angina: 26 patients). The demography and severity of symptoms for each group were analysed. The endpoints were success rate, 30 day mortality, complications and patient's satisfaction.
99 patients had bilateral VATS sympathectomy and 1 had unilateral sympathectomy. The conversion rate to open was 1(1%). All patients had successful removal of ganglia proven histologically with no perioperative mortality in our series. The complications included pneumothorax (5%), acute coronary syndrome (2%), transient Horner's syndrome (1%), transient paraesthesia (1%), wound infection (4%), compensatory hyperhidrosis (18%), residual flushing (3%) and wound pain (5%). There were five late deaths in the intractable angina group at a mean follow up of 36.7 months. Overall success rates of abolishing the symptoms were 96.3%, 87.5% and 95.2% for Group 1, 2 and 3 respectively.
Excision of the sympathetic chain with histological confirmation during VATS sympathectomy is a safe and effective method in treating hyperhidrosis, facial flushing and intractable angina with good long term results and satisfaction.
电视辅助胸腔镜交感神经切除术(VATS)是一种成熟的微创手术,用于治疗多汗症、面部潮红和顽固性心绞痛患者的胸交感神经阻滞。采用夹子、透热疗法和切除术等多种技术来实施交感神经切除术。我们介绍了切除交感神经链并提供组织学证据的技术以及对早期和晚期结果的分析。
我们评估了100例连续患者中的200例手术,这些患者于1996年9月至2007年3月在我们中心由一名外科医生进行了电视辅助胸腔镜交感神经切除术。所有患者在手术前均接受了最大程度的药物治疗,并根据适应症分为3组,第1组(多汗症:48例患者),第2组(面部潮红:26例患者)和第3组(顽固性心绞痛:26例患者)。分析了每组的人口统计学和症状严重程度。终点指标为成功率、30天死亡率、并发症和患者满意度。
99例患者接受了双侧VATS交感神经切除术,其中1例接受了单侧交感神经切除术。转为开放手术的比例为1(1%)。在我们的系列研究中,所有患者均成功切除了经组织学证实的神经节,且无围手术期死亡。并发症包括气胸(5%)、急性冠状动脉综合征(2%)、短暂性霍纳综合征(1%)、短暂性感觉异常(1%)伤口感染(4%)、代偿性多汗症(18%)、残余潮红(3%)和伤口疼痛(5%)。在顽固性心绞痛组中,平均随访36.7个月时有5例晚期死亡。第1、2和3组消除症状的总体成功率分别为96.3%、87.5%和95.2%。
在VATS交感神经切除术中切除交感神经链并经组织学证实是治疗多汗症、面部潮红和顽固性心绞痛的一种安全有效的方法,长期效果良好且患者满意度高。